Cargando…
Enhanced Production of a Novel Cyclic Hexapeptide Antibiotic (NW-G01) by Streptomyces alboflavus 313 Using Response Surface Methodology
NW-G01, produced by Streptomyces alboflavus 313, is a novel cyclic hexapeptide antibiotic with many potential applications, including antimicrobial activity and antitumor agents. This study developed a system for optimizing medium components in order to enhance NW-G01 production. In this study, Plac...
Autores principales: | Guo, Zhengyan, Shen, Ling, Ji, Zhiqin, Wu, Wenjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344276/ https://www.ncbi.nlm.nih.gov/pubmed/22606040 http://dx.doi.org/10.3390/ijms13045230 |
Ejemplares similares
-
Lunaemycins, New Cyclic Hexapeptide Antibiotics from the Cave Moonmilk-Dweller Streptomyces lunaelactis MM109(T)
por: Martinet, Loïc, et al.
Publicado: (2023) -
Streptomyces alboflavus RPS and Its Novel and High Algicidal Activity against Harmful Algal Bloom Species Phaeocystis globosa
por: Zhang, Bangzhou, et al.
Publicado: (2014) -
Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis
por: Rollo, Rachel F., et al.
Publicado: (2023) -
Antibacterial Activity Composition of the Fermentation Broth of Streptomyces djakartensis NW35
por: Zhang, Wenjuan, et al.
Publicado: (2013) -
Modulation of Oral Bioavailability and Metabolism for Closely Related Cyclic Hexapeptides
por: Vorherr, Thomas, et al.
Publicado: (2017)